Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105087744A details DKR method for high-purity S-5-methyl-1-amino indan. Offers cost reduction in pharma manufacturing and supply chain reliability.
Patent CN104628720A offers high purity moxifloxacin hydrochloride refining. Enhances supply chain reliability and cost reduction in pharmaceutical manufacturing.
Discover the patented immobilized catalyst method for N,N-diallyl-5-methoxytryptamine hydrochloride. Achieve high purity and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN102503842B details amino alkoxy curcumin derivatives enhancing solubility and anti-tumor activity for cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104193749A reveals a one-pot synthesis for antineoplastic isatin derivatives. This report analyzes cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN105348063A reveals a novel synthesis method for Paeonol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113527168B reveals a novel acid-base extraction method for Vildagliptin, achieving over 90% yield and controlling disubstituted impurities below 0.1% without repeated recrystallization.
Novel phthalimide route for brexpiprazole intermediate offers high purity and yield, significantly reducing costs for API manufacturers.
Patent CN110003110B reveals a green photocatalytic route for aryl beta-aminoketones, offering cost reduction and mild conditions for pharmaceutical manufacturing.
Novel vanadium catalyst method for heterocyclic amides. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing. Enhances purity and scalability.
Novel synthesis route for Vb compound avoids palladium and butyllithium ensuring high purity and cost reduction for pharmaceutical intermediates manufacturing supply chain.
Patent CN116082335A reveals a convergent synthesis for diaryl ethers using cesium salts, offering superior yields and eliminating heavy metal contaminants for reliable API manufacturing.
Patent CN108752232B details a green photocatalytic method for alpha-quaternary amino acids using CO2, offering safer alternatives to toxic Strecker reactions for pharma supply chains.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN104178540B reveals a high-yield E. coli biocatalysis route for Ademetionine, offering superior purity and streamlined manufacturing for global supply chains.
Novel Pictet-Spengler and Heck coupling strategy enables scalable production of anti-inflammatory alkaloid Arbornamine with improved cost efficiency.
Patent CN104860867B details Mn-catalyzed synthesis offering high yields. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN119613241B introduces iodine-catalyzed photocatalysis for menadione. Offers high yield, continuous flow scalability, and reduced toxic waste for reliable pharmaceutical intermediates supply chains.
Patent CN115385909A details a novel Pd/Cu method for imidazophenanthridines, offering mild conditions and high purity for pharmaceutical intermediates.
Patent CN110563623A reveals a novel L-(+)-selenomethionine synthesis using selenium powder. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.